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Abstract
Objective: This study assessed the percentage and type of 
congenital anomalies diagnosed at first-trimester ultra-
sound (US) scan in a primary care setting without following 
a standardized protocol for fetal anatomical assessment. 
Materials and Methods: US scans performed between 11+0 
and 13+6 weeks of gestation in pregnancies with estimated 
date of delivery between January 1, 2012 and January 1, 
2016 were searched. Data were supplemented with results 
of 20-week scans and pregnancy outcome. Results: Of all 
scans, 38.6% were dating scans and 61.4% were part of first-
trimester screening. Anomalies were diagnosed prenatally 
in 200 (1.8%) fetuses; 81 (0.7%) were chromosomal and 119 
(1.1%) were structural. Of all prenatally detected anomalies, 
27% (n = 32) were detected at first-trimester scan, with a 
false-positive rate of 0.04%. All cases of anencephaly (n = 4), 
encephalocele (n = 2), exomphalos (n = 9), megacystis (n = 
4), and limb reduction (n = 1) were diagnosed. First-trimester 
detection of gastroschisis and congenital heart defects was 
67 and 19%, respectively. Conclusion: In a primary care set-
ting, global fetal anatomical assessment at first-trimester 
scan without following a standardized protocol detects 
about 30% of all structural anomalies and most of the severe 
anomalies, with an extremely low false-positive rate. We hy-
pothesize that additional training and use of a systematic 
protocol would improve early detection of structural anom-
alies. © 2018 The Author(s)
Published by S. Karger AG, Basel
Introduction
Prenatal screening has been rapidly and continuously 
evolving since its introduction in the seventies [1]. Since 
2007, pregnant women in the Netherlands can opt for 
first-trimester screening (FTS) by the combined test be-
tween 11+0 and 13+6 weeks of pregnancy and the anoma-
ly scan at around 20 weeks. Since 2017, genome-wide cell-
free fetal DNA (cffDNA) has become available for all 
women as first-tier screening from 10 weeks of pregnan-
cy onwards. This has led to a drastic decrease in the up-
take of the combined test. As a side effect of this new 
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
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screening strategy, early detection of major structural 
anomalies has also been affected. First-trimester scans are 
currently mainly performed for dating the pregnancy at 
about 9–10 weeks, and in the majority of cases no more 
scans are performed before the 20-week anomaly scan.
Prior to the introduction of cffDNA, the uptake of the 
FTS was about 35%, and this has hardly changed with the 
new screening offer. Conversely, the vast majority of 
women choose for screening for structural anomalies, 
with an uptake of > 90%.
Although FTS was primarily offered as screening for 
aneuploidies, a global, but not systematic survey of fetal 
anatomy was frequently carried out while attempting to 
obtain a good nuchal translucency (NT) measurement. 
Recent studies showed that an early anatomical scan at 
12–13 weeks, performed by an experienced sonographer 
instructed to follow a protocol, can detect over 40% of all 
structural anomalies and almost 100% of the severe ones 
[2–4]. However, it is not yet known whether a dating scan, 
performed at 12–13 weeks, would serve in this purpose or 
if a more detailed ultrasound (US) examination should be 
recommended. The primary aim of this study was to in-
vestigate the percentage and type of congenital anomalies 
diagnosed during a scan performed for dating of the preg-
nancy, as opposed to the scan performed as part of the 
FTS. The study also reports on the percentage and type of 
anomalies that remain undiagnosed at the first-trimester 
scan and that are only detected at the 20-week anomaly 
scan.
Methods
This is a retrospective study performed in a primary care US 
clinic in Rotterdam, The Netherlands. Cases were included if an 
US scan was performed between 11+0 and 13+6 weeks of gestation 
and if the estimated date of delivery was between January 1, 2012 
and January 1, 2016. Pregnancies were excluded from the study if 
a nonviable pregnancy was seen at the time of the first scan or if in 
fetuses with a normal first-trimester scan no information on the 
second-trimester anomaly scan (18+0 to 22+6 weeks) was available. 
If an abnormal marker or an anomaly was diagnosed, pregnancy 
outcome and postnatal follow-up were searched, and if these were 
not available, the case was excluded (Fig. 1). In case of suspicion of 
anomalies, additional information on referrals to a fetal medicine 
unit was included, genetic investigations and pathology reports 
were retrieved from the clinic databases, and the national birth 
registry and the pathology and clinical genetics department of the 
tertiary care center were consulted. All patient and US data were 
entered into an electronic database (clinical package Astraia 
GmbH, Munich, Germany). The retrieved data needed for the 
study were extracted from the clinical package, anonymized, and 
subsequently transferred to Microsoft Access. SPSS Statistics ver-
sion 23.0 (IBM Corp., Armonk, NY, USA) was used to perform 
descriptive and comparative statistics. All results were considered 
statistically significant with α < 0.05.
First-Trimester Scan
All women attending the clinic underwent an US scan at 11+0 
to 13+6 weeks, either in the setting of a dating scan or as part of the 
nuchal scan in the FTS. The following US systems were used for 
the examinations: EPIQ-7, IU22, Aloka SSD 3500, Aloka alpha 6, 
Philips HD (7, 11, and 15), and ATL HDI 5000 with curved array 
transducers. Transabdominal and transvaginal scans were per-
formed with 9–1 and 10–3 MHz probes, respectively. US examina-
tions were always started transabdominally and only occasionally 
the transvaginal route was used owing to technical difficulties, 
mainly because of a high body mass index. Sonographers were in-
structed to confirm viability, determine the number of fetuses, and 
measure crown-rump length in order to accurately establish ges-
tational age. Moreover, the following biometric measurements 
were performed: biparietal diameter, abdominal circumference, 
head circumference, and femur length. In women choosing FTS, 
PAPP-A and free β-hCG levels were also determined in maternal 
serum, and NT was measured to calculate the risk of aneuploidy 
according to the Fetal Medicine Foundation (FMF) algorithm. 
While waiting for an optimal fetal position for the NT measure-
ment, the sonographer also performed within the time allocated 
for the FTS a global anatomical survey, but without following a 
standardized protocol. All FTSs were performed by FMF-certified 
sonographers, while dating scans were performed with the same 
US equipment in 36.5% of cases by FMF-certified and in 63.5% by 
non-FMF-certified, but experienced sonographers, similarly in-
structed to globally investigate the fetal anatomy. The time al-
located for the investigations was 20 min for a dating scan and 
30 min for FTS.
Classification of Anomalies
All fetal anomalies reported in the study were subdivided into 
different categories depending on the organ system affected: cen-
tral nervous system (including neural tube defects and brain), fa-
cial, respiratory, cardiac, gastrointestinal, abdominal wall, uri-
nary, genital, skeletal, and others. Fetuses with two or more dif-
ferent (i.e., different localized errors in morphogenesis) major 
anomalies were included in the “multiple congenital anomalies” 
group [5]. Fetuses with more than one anomaly of different sever-
ity were classified based on the most severe anomaly. Also, for 
fetuses with multiple anomalies, the diagnosis was considered as 
made prenatally when the most severe anomaly was identified 
prenatally. Structural anomalies in fetuses with a chromosomal 
anomaly confirmed by amniocentesis or chorionic villus sam-
pling were excluded. Familiar or nonpathological variants of nor-
mal anatomy (e.g., short femur, persistent left superior vena cava) 
were not considered as structural anomalies. Also, no distinction 
was made between cystic hygroma and NT ≥3.5 mm, as there is 
an overlap between first-trimester US appearance in excessive nu-
chal fluid collection. Cardiac defects diagnosed in a referral center 
owing to presence of one or more US markers (i.e., abnormal duc-
tus venosus Doppler, abnormal heart axis, tricuspid regurgita-
tion) observed at 11+0 to 13+6 weeks and prompting referral to a 
tertiary center were considered as detected during the first trimes-
ter.





During the inclusion period, 13,417 pregnancies un-
derwent an US scan between 11+0 and 13+6 weeks. First, 
154 cases (1.1%) were excluded because of fetal demise 
observed at the time of the first-trimester scan. The preg-
nancy losses were observed at 11, 12, and 13 weeks in 81 
(52.6%), 60 (39.0%), and 13 (8.4%) of the scans per-
formed, respectively. Second, 2,374 (17.7%) cases were 
excluded because of missing second-trimester scan data 
and 81 (0.7%) because of fetal chromosomal anomalies. 
In total, information on anomalies detected at the first- or 
second-trimester scan was available in 10,808 pregnan-
cies. Mean maternal age was 30.9 (range 15–46) years and 
median body weight 67 (range 42–163) kg.
Of all first-trimester scans, 4,190 (38.8%) were dating 
scans and 6,618 (61.2%) FTS scans. The mean gestational 
age at the time of evaluation was 12+1 days for dating 
scans and 12+3 days for FTS. The prevalence of congenital 
anomalies in the study population was 1.8% (n = 200), 
including 81 (0.7%) chromosomal and 119 (1.1%) struc-
tural anomalies diagnosed prenatally. First-trimester di-
agnosis of structural anomalies was 26.9% (32/119).
Chromosomal Anomalies
A total of 81 (0.7%) fetuses were diagnosed with a 
chromosomal anomaly: trisomy 21 (n = 38, 46.9%), tri-
somy 18 (n = 11, 13.6%), trisomy 13 (n = 6, 7.4%), Tur-
ner syndrome (n = 5, 6.2%), triploidy (n = 5, 6.2%), 
microscopic aberrations (n = 15, 18.5%) detected by 
microarrays, and 1 case (1.2%) with abnormal but oth-
erwise unspecified karyotype. The first-trimester diag-
nosis rate for chromosomal anomalies was 77.7% (n = 
63) (Table 1).
11+0 to 13+6 week scan
(n = 13,417)
Spontaneous fetal death (n = 154)
No second-trimester scan (n = 2,374)






(n = 12) 
Anomaly
(n = 20) 
No anomaly
(n = 10,635) 
Anomaly
(n = 87) 
20-week scan
(n = 10,722)
TOP* (n = 8)









*3 patients with NT ≥95th percentile and high risk at FTS but no karyotyping performed, 
     others TOP for social reasons (n = 5)
**3 patients with NT ≥95th percentile but no karyotyping performed, others spontaneous IUD <20 weeks (n = 43)
FTS scan
(n = 6,618)
Fig. 1. Flowchart of the patient population. FTS, first-trimester screening; IUD, intrauterine death; NT, nuchal 
















In the study population, a total of 119 (1.1%) struc-
tural anomalies were detected either at the first- or at the 
second-trimester scan (Table 2). This gives a total preva-
lence of 1.1%. Of these, 32 (26.9%) were detected in the 
first trimester. Of the anomalies diagnosed at first-trimes-
ter scan, 18 (56.3%) resulted in termination of pregnancy, 
2 (6.3%) in spontaneous fetal demise, and 12 (37.5%) in 
live births (Table 2).
Eleven out of 12 (91.7%) abdominal wall defects were 
diagnosed in the first trimester; omphalocele was detect-
ed in all cases (9/9), while gastroschisis was detected in 
2/3 cases (66.7%).
Multiple congenital anomalies were diagnosed in 3/5 
(60%) of cases and anomalies of the central nervous sys-
tem in 6/14 (42.9%). In the latter group, all cases of acra-
nia (n = 4) and encephalocele (n = 2) were detected at the 
first-trimester scan, while all other anomalies, including 
3 cases of spina bifida, were overlooked at the early scan.
The overall detection of cardiac anomalies at first-tri-
mester scan was 19.0% (4/21); in 2 cases of tetralogy of 
Fallot (2/4) and 2 cases of complex heart defects (one with 
dextrocardia, mitral valve atresia, and hypoplastic aorta, 
the other with double-outlet right ventricle), first-trimes-
ter markers or suspicious findings prompted the referral 
to a third-level center. All remaining cardiac defects were 
diagnosed at the 20-week scan.
Of all skeletal anomalies, 17.6% (3/17) were diagnosed 
in the first trimester. Anomalies detected at the early scan 
included the only case of limb reduction (1/1) as well as 
1/3 cases of skeletal dysplasia. All other minor skeletal 
anomalies, with the exception of 1/3 cases of polydactyly, 
were diagnosed at the second-trimester scan.
Five out of 33 (15.2%) urogenital anomalies were diag-
nosed in the first trimester. This included all cases of 
megacystis (n = 4) and 1/5 cases of unilateral renal agen-
esis. All other urogenital anomalies, including multicystic 
renal dysplasia, hydronephrosis, ureterocele, and double 
collecting kidneys were diagnosed at the 20-weeks scan.
Overall, no cases of gastrointestinal, respiratory, or fa-
cial anomalies were detected in the first trimester. These 
included 3 diaphragmatic hernia, 1 esophageal and 1 du-
odenal atresia, 5 congenital adenomatoid malformations 
of the lung, and 7 cases of cleft lip and/or palate.
In the study four false-positive diagnoses were record-
ed, giving a first-trimester false-positive rate of 0.04%. 
These included 2 cases of megacystis < 15 mm that re-
solved spontaneously and 2 cases of (bowel-only) ompha-
locele that also resolved spontaneously in the second tri-
mester of pregnancy. All these pregnancies resulted in 
live births.
Visualization of Fetal Organs at First-Trimester Scan
Of the 32 anomalies diagnosed in the first trimester, 26 
(81.3%) were detected by FMF-trained sonographers. Al-
though detection was not dissimilar between the two 
types of investigations, the time reserved for the scan in-
fluenced the success of the anatomical survey: completed 
in 4,030/6,618 (60.9%) of the FTS as opposed to in 
868/4,190 (20.7%) of the dating scans (p < 0.001).
Regression analysis was then performed to identify the 
factors contributing to the successful visualization of fetal 
Table 1. Fetal chromosomal anomalies in the study population
Chromosomal anomaly Total Diagnoses Outcome
11–13 weeks 18–22 weeks >22 weeks TOP IUD live birth
Trisomy 21 38 (46.9) 28 (73.7) 8 (21.1) 2 (5.2) 32 (84.2) 1 (2.6) 5 (13.2)
Trisomy 18 11 (13.6) 11 (100) – – 11 (100) – –
Trisomy 13 6 (7.4) 6 (100) – – 6 (100) – –
Turner syndrome (45X0)a 5 (6.2) 3 (60) – 2 (40)a 3 (60) – 2 (40)a
Triploidy 5 (6.2) 5 (100) – – 4 (80) 1 (20) –
Microscopic aberrationsb 15 (18.5) 9 (60) 5 (33.3) 1 (6.7) 4 (26.7) 3 (20) 8 (53.3)
Unknown 1 (1.2) 1 (64.3) – – 1 (100) – –
Total 81 63 (77.7) 13 (16) 5 (6.2) 59 (75.6) 5 (6.4) 14 (17.9)
Values are presented as n (%). IUD, intrauterine death; TOP, termination of pregnancy. a Two patients with mosaic 45X0. b Including: 
gain 16p13.11p12.3 (n = 1), gain 22q11.2 (n = 2), (1–22) x2 (XY) x1 (n = 1), 4q del (n = 1), LMX1B mutation (n = 1), del 22q11.2 (n = 
2), del 2q37 (n = 1), gain 1q21.1 (n = 1), q5 del (n = 1), trans 9–13 (n = 1), q13 del (n = 1), q2 duplication (n = 1), 3q2 del (n = 1).




Table 2. Structural anomalies in the study population and pregnancy outcomes
Fetal anomaly Total Diagnoses Pregnancy outcome
11+0 to 13+6 weeks (n = 32) 20–23 weeks 
(FTS/DS)b
TOP IUD live birth
1st trimestera FTS DS
Central nervous system 14
Acrania/exencephaly 4 4/4 (100) – 4 – 4 (100) – –
Encephalocele 2 2/2 (100) 2 – – 2 (100) – –
Hydrocephaly 2 – – – 2 (1 FTS/1 DS) 1 (50) – 1 (50)
Schizencephaly 1 – – – 1 (FTS) 1 (100) – –
Corpus callosum agenesis 1 – – – 1 (FTS) 1 (100) – –
Craniosynostosis 1 – – – 1 (FTS) – – 1 (100)
Spina bifida 3 – – – 3 (DS) 2 (67) 1 (33) –
Facial 7
Cleft lip 1 – – – 1 (FTS) – – 1 (100)
Cleft palate 1 – – – 1 (DS) – – 1 (100)
Cleft lip and palate 5 – – – 5 (4 FTS/1 DS) – – 5 (100)
Respiratory 8
CAML 5 – – – 5 (3 FTS/2 DS) – – 5 (100)
Hernia diaphragmatica 3 – – – 3 (FTS) 1 (33) – 2 (67)
Cardiac 21
Double-outlet right ventricle 1 – – – 1 (FTS) – – 1 (100)
Transposition great arteries 2 – – – 2 (FTS) – – 2 (100)
Coarctation of the aorta 1 – – – 1 (FTS) – – 1 (100)
Extended aortic arch 1 – – – 1 (DS) – – 1 (100)
Tetralogy of Fallot 4 2/4 (50) 2 – 2 (1 FTS/1 DS) 2 (50) – 2 (50)
Hypoplastic left heart 1 – – – 1 (DS) 1 (100) – –
Atrial septal defect 1 – – – 1 (DS) – – 1 (100)
Atrioventricular septal defect 2 – – – 2 (1 FTS/1 DS) – 1 (50) 1 (50)
Cor triatriatum dexter 1 – – – 1 (FTS) – – 1 (100)
Aortic valve stenosis 1 – – – 1 (FTS) 1 (100) – –
Tricuspid insufficiency 1 – – – 1 (FTS) – – 1 (100)
Aortic aneurysm 1 – – – 1 (FTS) – – 1 (100)
Right aortic arch 1 – – – 1 (FTS) – – 1 (100)
Complex heart defectc 3 2/3 2 – 1 (FTS) 2 (67) 1 (33) –
Gastrointestinal 2
Esophageal atresia 1 – – – 1 (FTS) – – 1 (100)
Duodenal atresia 1 – – – 1 (FTS) – 1 (100) –
Abdominal wall 12
Gastroschisis 3 2/3 (67) 2 – 1 (FTS) – 1 (33) 2 (67)
Omphaloceled 9 9/9 (100) 4 5 – 4 (44.4) – 5 (55.6)
Urogenital 33
Unilateral renal agenesis 5 1/5 (20) 1 – 4 (4 FTS/1 DS) 1 (20) – 4 (80)
Megacystis 4d 4/4 (100) 2 2 – 2 (50) – 2 (50)
Unilateral multicystic renal dysplasia 8 – – – 8 (5 FTS/3 DS) – – 8 (100)
Bilateral multicystic renal dysplasia 2 – – – 2 (1 FTS/1 DS) 2 (100) – –
Unilateral hydronephrosis 7 – – – 7 (5 FTS/2 DS) – – 7 (100)
Bilateral hydronephrosis 4 – – – 4 (3 FTS/1 DS) 1 (25) – 3 (75)
Unilateral ureterocele 1 – – – 1 (FTS) – – 1 (100)
Double collecting system 2 – – – 2 (FTS) – – 2 (100)
Skeletal 17
Limb reduction 1 1/1 (100) 1 – – – – 1 (100)
Polydactyly 3 1/3 (33) 1 – 2 (FTS) – – 3 (100)
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organs at first-trimester scan. This revealed that women 
undergoing FTS – lasting 30 min – had a 5.6 times higher 
chance of successful visualization of all fetal organs com-
pared to women who underwent a dating scan (p < 0.001). 
Also, an increase of gestational age by 1 week significant-
ly increased the likelihood of visualization of all fetal or-
gans by 1.7-fold (p < 0.01); all organs were successfully 
visualized in 24% of scans performed at 11 weeks, 50% at 
12 weeks, and 52% at 13 weeks of gestation.
Discussion
This study showed that a global survey of the fetal 
anatomy between 11+0 to 13+6 weeks of gestation can de-
tect about 30% of all prenatally diagnosed structural 
anomalies and that especially the severe ones are ame-
nable to early detection. Factors contributing to a success-
ful detection are the gestational age at the moment of the 
scan, with higher rates at 13 compared to 11 weeks, and 
the time allocated for the examination, with more suc-
cessful complete visualization of the fetal anatomy if the 
scan is part of the FTS rather than a dating scan. Another 
important factor was the extremely low false-positive rate 
(0.04%) of early US investigation, confirming our previ-
ous report [4]. Moreover, all four false-positive cases con-
cerned defects with a great chance of resolution later in 
pregnancy, and women were therefore counseled accord-
ingly.
The early detection of anomalies in our study is in line 
with previous reports on low-risk populations, performed 
without adherence to a strict protocol and showing a de-
tection rate of about 30% [6]. Detection can double and 
can even equal that of second-trimester scans if sonogra-
phers are specifically trained to investigate the fetal anat-
omy systematically [6–8].
The study by Syngelaki et al. [2] is to this date the larg-
est study on early detection of structural anomalies at 
the nuchal scan, with a detection rate of 44%. Based on 
the literature, the authors suggested that besides the “al-
ways detectable” major anomalies, there is an additional 
42% of potentially detectable anomalies, the recognition 
of which depends on the experience of the sonographer, 
the quality of the equipment, and maternal characteris-
tics such as body mass index. In our study, all “always 
detectable” anomalies (anencephaly, large exomphalos, 
megacystis, and severe limb defects) were indeed diag-
nosed in the first trimester. Others, such as gastroschisis, 
proved again to be more challenging for an early diag-
nosis [4].
Fetal anomaly Total Diagnoses Pregnancy outcome
11+0 to 13+6 weeks (n = 32) 20–23 weeks 
(FTS/DS)b
TOP IUD live birth
1st trimestera FTS DS
Syndactyly and oligodactyly 1 – – – 1 (FTS) – – 1 (100)
Club foot unilateral 2 – – – 2 (FTS) – – 2 (100)
Club feet bilateral 6 – – – 6 (FTS) – – 6 (100)
Rocker bottom feet 1 – – – 1 (FTS) – – 1 (100)
Skeletal dysplasia 3 1/3 (33) 1 – 2 (FTS) 1 (33) – 2 (67)
Others
Multiple congenital anomaliese 5 3/5 (60) 2 1 2 (FTS) 3 (60) – 2 (40)
Total 119 32 (27) 20 12 87 32 (27) 5 (4) 82 (69)
Values are presented as n (%). CAML, congenital adenomatoid malformation of the lung; DS, dating scan; FTS, first-trimester screen-
ing; IUD, intrauterine death; TOP, termination of pregnancy. a Detected in the first trimester. b Number of fetuses who underwent DS 
versus FTS. c One case with dextrocardia, hypoplastic aorta, and aplastic mitral valve, 1 case with transposition of the great arteries and 
double-outlet right ventricle, and 1 case with unspecified multiple heart defects. d Two cases of megacystis <15 mm with spontaneous 
resolution and 2 cases of bowel-only omphalocele with spontaneous resolution. e One case with omphalocele, split hand, dimorphic face, 
and abnormal skull shape; 1 case with omphalocele and missing foot; 1 case with bilateral hydronephrosis, polydactyly, and ventriculo-
megaly, and CHARGE syndrome postnatally; 1 case with nasal tumor, cleft lip and palate, hypertelorism, flat nose, dilated heart, and 
atrial septal defect; 1 case with unspecified heart anomaly, increased nuchal translucency, and missing nasal bone (no karyotype done).
Table 2 (continued)




In our study we compared early detection at 12–13 
weeks with detection at 20 weeks, without including 
anomalies detected only after birth. We therefore pre-
ferred not to use the terminology “detection rate.” How-
ever, our observed prevalence of structural anomalies 
(1.1%) is similar to that reported by Syngelaki et al. [2], 
which is reassuring as to the representativeness of our re-
sults, in spite of lack of inclusion of postnatal follow-up. 
Future prospective studies should overcome this limita-
tion.
The low prevalence of cardiac defects in our popula-
tion (0.2%) suggests that some cardiac anomalies (coro-
nary heart disease) probably also remain undetected at 
the 20-week scan. Of the prenatally diagnosed coronary 
heart disease cases, only 19.0% (4/21) were diagnosed in 
the first trimester. This is lower than the 26.4% reported 
by Syngelaki et al. [2] and the 56% reported by Grande et 
al. [3], but higher than in other previous studies [9, 10]. 
In a protocol for first-trimester detection of anomalies, 
the use of a combination of markers such as NT, ductus 
venosus flow, tricuspid regurgitation, and measurement 
of the cardiac axis has the potential of significantly in-
creasing detection rates [11–13].
All sonographers involved in our study were experi-
enced, but had different levels of training. Those per-
forming the FTS were FMF-certified and audited yearly, 
while most of those performing the dating scans had only 
basic US knowledge.
Retrospective assessment of the images of anomalies 
missed by non-FMF-trained sonographers (3 spina bifida 
cases and of 4/5 facial clefts) showed that early markers of 
abnormal development, such as absent intracranial trans-
lucency [14] and abnormal maxilla-nasion-mandible an-
gle, were clearly visible [15]. This suggests that further 
training in recognition of these markers might have in-
creased detection of these cases.
The lack of a systematic assessment of fetal anatomy in 
our study applies especially to the dating scan group. In 
the Netherlands, guidelines recommend performance of 
dating scans no earlier than at 8+4 weeks and ideally be-
tween 10+0 and 12+6 weeks. In reality, most dating scans 
are performed by midwives at around or before 10 weeks 
of gestation. The only requirement is a correct crown-
rump length measurement, with no quality control of op-
erator experience and US equipment used. This study 
therefore reports on an unusual situation, where dating 
scans were postponed to beyond 11 weeks and performed 
by experienced sonographers, although not all trained in 
FTS. This policy was intentionally chosen by the US clin-
ic where the study was performed to enable early screen-
ing for structural anomalies even in women not choosing 
FTS, but valuing early detection of structural defects.
The study did not show significant differences in the 
number of anomalies detected at dating or FTS scans. 
However, anomalies detected at dating scans (acrania, 
omphalocele, and megacystis) were more obvious than 
those detected at FTS (cardiac anomalies, renal agenesis, 
and polydactyly). Moreover, the organ visualization rate 
at FTS was significantly higher than at dating scans (73.6 
vs. 24.1%, p < 0.001).
In line with previous studies [16, 17], this study indicates 
that training and education play a major role in the success-
ful completion of a detailed US examination and that the 
optimal time for a first-trimester scan is 12–13 weeks [18, 
19], when most fetal organs are sufficiently developed [14, 
20, 21], their visualization can be complete in 86% of cases 
[22], the majority of spontaneous losses have already oc-
curred (from 81 at 11 weeks to 13 at 13 weeks) [23], and only 
3% may still occur thereafter [24]. In a previous prospective 
study by our group, we showed that when sonographers are 
instructed to perform a survey of fetal anatomy at the early 
scan, the detection rate can increase to 45% [4].
The importance of an early diagnosis is that it allows 
more time for additional investigations, repeat US exam-
inations, and informed parental decision making regard-
ing the course of pregnancy. If termination of pregnancy 
is chosen, this can occur without time constraint and with 
less psychological and medical sequelae than at a later 
stage [25, 26]. This is also the main reason for women to 
prefer early screening [27]. Indeed, the relatively high 
percentage of termination of pregnancy after early detec-
tion of anomalies in this study is explained by their sever-
ity. Early diagnosis becomes especially important with 
the introduction of prenatal wide exome sequencing [28, 
29]. In case of anomalies with normal array comparative 
genomic hybridization, there is still enough time to carry 
out this advanced genetic investigation within the legal 
term for termination in most countries.
To conclude, in view of the strong decline in FTS after 
the introduction of cffDNA as first-tier screening for an-
euploidies, we recommend the introduction of a 12–13-
week scan as first part of the routine anomaly screening 
in pregnancy, as this enables early identification of se- 
vere anomalies. The screening can then be completed at 
around 20 weeks and target especially the more challeng-
ing organs, such as the brain and heart. We anticipate that 
additional training of sonographers and use of the vaginal 
route when visualization is suboptimal will significantly 
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